These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3335690)

  • 21. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
    McKenna WJ; Oakley CM; Krikler DM; Goodwin JF
    Br Heart J; 1985 Apr; 53(4):412-6. PubMed ID: 4039188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of arrhythmias in hypertrophic cardiomyopathy.
    Stewart JT; McKenna WJ
    Cardiovasc Drugs Ther; 1994 Feb; 8(1):95-9. PubMed ID: 8086333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability of ventricular arrhythmias in hypertrophic cardiomyopathy and implications for treatment.
    Mulrow JP; Healy MJ; McKenna WJ
    Am J Cardiol; 1986 Sep; 58(7):615-8. PubMed ID: 2428233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentially lethal arrhythmias and their management in hypertrophic cardiomyopathy.
    Frank MJ; Watkins LO; Prisant LM; Stefadouros MA; Abdulla AM
    Am J Cardiol; 1984 Jun; 53(11):1608-13. PubMed ID: 6539560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone.
    Fananapazir L; Epstein SE
    Am J Cardiol; 1991 Jan; 67(2):175-82. PubMed ID: 1987719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertrophic cardiomyopathy: an important cause of sudden death.
    McKenna WJ; Deanfield JE
    Arch Dis Child; 1984 Oct; 59(10):971-5. PubMed ID: 6541894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiologic studies of patients with hypertrophic cardiomyopathy presenting with syncope of undetermined etiology.
    Schiavone WA; Maloney JD; Lever HM; Castle LW; Sterba R; Morant V
    Pacing Clin Electrophysiol; 1986 Jul; 9(4):476-81. PubMed ID: 2426664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk of syncope in hypertrophic cardiomyopathy: a multivariate analysis of prognostic variables].
    Nienaber CA; Hiller S; Spielmann RP; Geiger M; Kuck KH
    Z Kardiol; 1990 Apr; 79(4):286-96. PubMed ID: 2356642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features.
    McKenna W; Deanfield J; Faruqui A; England D; Oakley C; Goodwin J
    Am J Cardiol; 1981 Mar; 47(3):532-8. PubMed ID: 7193406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sudden death in hypertrophic and dilated cardiomyopathy.
    Koga Y; Ogata M; Kihara K; Tsubaki K; Toshima H
    Jpn Circ J; 1989 Dec; 53(12):1546-56. PubMed ID: 2632825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wavelet decomposition analysis of the signal averaged electrocardiogram used for risk stratification of patients with hypertrophic cardiomyopathy.
    Englund A; Hnatkova K; Kulakowski P; Elliot PM; McKenna WJ; Malik M
    Eur Heart J; 1998 Sep; 19(9):1383-90. PubMed ID: 9792265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of arrhythmias in hypertrophic cardiomyopathy: role of ambulatory monitoring and signal-averaged electrocardiography.
    Gavaghan TP; Kelly RP; Kuchar DL; Hickie JB; Campbell TJ
    Aust N Z J Med; 1986 Oct; 16(5):666-70. PubMed ID: 3469964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signal-averaged electrocardiography in hypertrophic cardiomyopathy.
    Cripps TR; Counihan PJ; Frenneaux MP; Ward DE; Camm AJ; McKenna WJ
    J Am Coll Cardiol; 1990 Apr; 15(5):956-61. PubMed ID: 2312981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways.
    Krikler DM; Davies MJ; Rowland E; Goodwin JF; Evans RC; Shaw DB
    Br Heart J; 1980 Mar; 43(3):245-51. PubMed ID: 7192150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypertrophic myocardiopathy. Course and prognosis. 60 cases].
    Cohen S; Benichou M; Larbi MB; Bory M; Serradimigni A
    Presse Med; 1986 Mar; 15(9):423-7. PubMed ID: 2938168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy.
    Fananapazir L; Leon MB; Bonow RO; Tracy CM; Cannon RO; Epstein SE
    Am J Cardiol; 1991 Jan; 67(2):169-74. PubMed ID: 1987718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.